These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 9691019)
1. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro. Tomita N; Horiuchi M; Tomita S; Gibbons GH; Kim JY; Baran D; Dzau VJ Am J Physiol; 1998 Aug; 275(2):F278-84. PubMed ID: 9691019 [TBL] [Abstract][Full Text] [Related]
2. Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis. Tomita N; Kim JY; Gibbons GH; Zhang L; Kaneda Y; Stahl RA; Ogborn M; Venderville B; Morishita R; Baran D; Dzau VJ Int J Mol Med; 2004 May; 13(5):629-36. PubMed ID: 15067361 [TBL] [Abstract][Full Text] [Related]
3. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Morishita R; Gibbons GH; Horiuchi M; Ellison KE; Nakama M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5855-9. PubMed ID: 7597041 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP. Park KK; Deok Ahn J; Lee IK; Magae J; Heintz NH; Kwak JY; Lee YC; Cho YS; Kim HC; Chae YM; Ho Kim Y; Kim CH; Chang YC Biochem Biophys Res Commun; 2003 Sep; 308(4):689-97. PubMed ID: 12927774 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates. Kawauchi M; Suzuki J; Morishita R; Wada Y; Izawa A; Tomita N; Amano J; Kaneda Y; Ogihara T; Takamoto S; Isobe M Circ Res; 2000 Nov; 87(11):1063-8. PubMed ID: 11090553 [TBL] [Abstract][Full Text] [Related]
6. Roles of E2F1 in mesangial cell proliferation in vitro. Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. Maeshima Y; Kashihara N; Yasuda T; Sugiyama H; Sekikawa T; Okamoto K; Kanao K; Watanabe Y; Kanwar YS; Makino H J Clin Invest; 1998 Jun; 101(11):2589-97. PubMed ID: 9616230 [TBL] [Abstract][Full Text] [Related]
8. [Inhibition on phenotypic transformation of detrusor smooth muscle cells after bladder outlet obstruction by E2F decoy strategy]. Gong Y; Du CJ; Ding LL; Song B; Jin XY Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):829-32. PubMed ID: 17565867 [TBL] [Abstract][Full Text] [Related]
9. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. Beier R; Bürgin A; Kiermaier A; Fero M; Karsunky H; Saffrich R; Möröy T; Ansorge W; Roberts J; Eilers M EMBO J; 2000 Nov; 19(21):5813-23. PubMed ID: 11060032 [TBL] [Abstract][Full Text] [Related]
10. Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia. Ahn JD; Morishita R; Kaneda Y; Kim HS; Chang YC; Lee KU; Park JY; Lee HW; Kim YH; Lee IK Gene Ther; 2002 Dec; 9(24):1682-92. PubMed ID: 12457282 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit. Hofmann F; Livingston DM Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921 [TBL] [Abstract][Full Text] [Related]
13. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Afshari CA; Nichols MA; Xiong Y; Mudryj M Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893 [TBL] [Abstract][Full Text] [Related]
14. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Kiess M; Gill RM; Hamel PA Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535 [TBL] [Abstract][Full Text] [Related]
17. Suppression of proliferative cholangitis by E2F decoy oligodeoxynucleotide. Yoshida M; Yamamoto N; Nitta T; Uehara T; Terao R; Hatano E; Iimuro Y; Yamaoka Y J Surg Res; 2002 Feb; 102(2):95-101. PubMed ID: 11796004 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of E2F-1 by cyclin A-cdk2. Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523 [TBL] [Abstract][Full Text] [Related]
19. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Lees E; Faha B; Dulic V; Reed SI; Harlow E Genes Dev; 1992 Oct; 6(10):1874-85. PubMed ID: 1398067 [TBL] [Abstract][Full Text] [Related]
20. Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells. Hosokawa Y; Yang M; Kaneko S; Tanaka M; Nakashima K Biochem Mol Biol Int; 1995 Oct; 37(2):393-9. PubMed ID: 8673024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]